FDA Fast-Tracks Licensure of MF59 Adjuvanted Influenza Vaccine
On Sept. 15, 2015 FDA advisors voted to fast-track MF59 adjuvanted influenza vaccine, despite safety concerns and the higher number of adverse reactions to Fluad vaccine.
ANOTHER Epic Fail for Influenza Vaccine
Flu vaccine effectiveness is measured from 0-62 percent as U.S. public health officials admit that the ineffective influenza vaccine is once again an epic fail.
FDA Approves Experimental H5N1 Bird Flu Vaccine with Reactive AS03 Adjuvant for U.S. Stockpile
How did squalene based bird flu vaccine make it into the U.S. Vaccine Stockpile? NVIC exposes safety issues associated the “oil-in-water” adjuvant present in this vaccine that has never before been licensed for use in the U.S.
Stephanie Christner Appointed to Serve on FDA’s Vaccine Advisory Committee
NVIC Board Member Dr. Stephanie Christner, a mother whose baby died after vaccine reactions, has been appointed to an FDA committee that evaluates vaccine safety and effectiveness data.